Image may be NSFW.
Clik here to view.
Clik here to view.
Epizyme Updates Clinical Trial Data on Tazemotostat for Mesothelioma, Other...
Epizyme has reported recent updates from its clinical-stage programs with the company’s lead candidate, tazemotostat, for the treatment of hematological malignancies and genetically defined solid...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Selecta Licenses LMB-100 for Combination Tests with SVP-Rapamycin in...
Selecta Biosciences has licensed to use and test the experimental anti-cancer drug LMB-100 from the Center for Cancer Research (CCR) at the National Cancer Institute (NCI). The agreement promotes...
View ArticleSelecta Licenses LMB-100 for Combination Tests with SVP-Rapamycin in...
Selecta Biosciences has licensed to use and test the experimental anti-cancer drug LMB-100 from the Center for Cancer Research (CCR) at the National Cancer Institute (NCI). The agreement promotes...
View Article
